Answers are grounded in this paper and cite their sources.
Cognitive impairment is a widespread feature of schizophrenia, affecting nearly 80 % of patients. Prior research has linked the anticholinergic burden of psychiatric medications to these cognitive deficits. However, the impact of the anticholinergic burden from medications for physical morbidity remains underexplored. This study aimed to evaluate the anticholinergic burden of psychiatric and physical medications in patients with schizophrenia and assess its impact on cognitive function.
No takes yet. Share an insight, caveat, or question.
Martínez-Cao et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: